Cell No. : Cell Name
RCB0527 : Jyg-MC(B)
update : 2022/03/17
|
Comment | Murine mammary tumor cell lines. Higher incidence in lung metastasis. |
Comment from the depositor | |
Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
Remarks | |
Order Form |
Order Form(C-0005.pdf)
 
MTA(C-0007.pdf)
 
MTA(C-0007p.pdf)
 
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
Basic information
|
Depositor |
Morimoto, Junji
|
Originator |
Morimoto, Junji
|
Year of deposit |
1990
|
Animal |
_mouse
< Mammals
|
Strain name |
JYG
|
Gender |
Female
|
Tissue |
mammary
|
Disease name |
mammary tumor
|
Metastatic ability |
Yes
|
Metastatic tissue |
lung,liver, spleen
|
Classification |
cancer
|
Year of origin |
1987
|
|
Lifespan |
infinite
|
Morphology |
epithelial-like
|
Cellosaurus(Expasy) |
CVCL_H217
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
Culture medium |
|
DMEM (low glucose) + 10% FBS
|
Antibiotics |
|
Free
|
|
Passage method |
|
0.25% Trypsin
|
Culture information
|
Passage ratio |
|
1 : 8 split
|
SC frequency |
|
Subculture : 2 times/week
|
Temperature |
|
37
℃
|
CO2 concentration |
|
5
%
|
Freeze medium |
|
Medium + 10% DMSO
|
Freezing method |
|
Slow freezing
|
Mycoplasma/Achoreplasma |
|
(-)
|
SSLP(mouse) |
|
OK
|
Isozyme |
|
LD, NP, G6PD, AST, MPI
|
Chromosome mode |
|
38-160(50) : /39(5),40(25),41(3),75(1),76(1),77(1)/
|
Images |
deposit info | lot info |
|
|
Reference information |
Reference |
9
|
User's Publication |
6
|
Reference |
979
Shibata MA, Ambati J, Shibata E, Albuquerque RJ, Morimoto J, Ito Y, Otsuki Y.
The endogenous soluble VEGF receptor-2 isoform suppresses lymph node metastasis in a mouse immunocompetent mammary cancer model
BMC Med
2010
8:69
PubMed ID: 21047425
|
986
Shibata MA, Shibata E, Morimoto J, Eid NA, Tanaka Y, Watanabe M, Otsuki Y.
An immunocompetent murine model of metastatic mammary cancer accessible to bioluminescence imaging
Anticancer Res
2009
29(11):4389-95
PubMed ID: 20032383
|
978
Shibata MA, Morimoto J, Shibata E, Otsuki Y.
Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model
Cancer Gene Ther
2008
15(12):776-86
PubMed ID: 18654613
DOI: 10.1038/cgt.2008.43
|
974
Shibata MA, Morimoto J, Akamatsu K, Otsuki Y.
Antimetastatic effect of suicide gene therapy for mouse mammary cancers requires T-cell-mediated immune responses
Med Mol Morphol
2008
41(1):34-43
PubMed ID: 18470679
DOI: 10.1007/s00795-007-0388-1
|
975
Shibata MA, Morimoto J, Doi H, Morishima S, Naka M, Otsuki Y.
Electrogene therapy using endostatin, with or without suicide gene therapy, suppresses murine mammary tumor growth and metastasis
Cancer Gene Ther
2007
14(3):268-78
PubMed ID: 17096028
DOI: 10.1038/sj.cgt.7701009
|
1004
Shibata MA, Morimoto J, Ito Y, Kusakabe K, Otsuki Y.
Experimental gene therapy in mammary and urinary bladder cancer using electrogene transfer
Med Electron Microsc
2004
37(4):216-24
PubMed ID: 15614446
DOI: 10.1007/s00795-004-0247-2
|
1001
Shibata MA, Morimoto J, Otsuki Y.
Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation
Cancer Gene Ther
2002
9(1):16-27
PubMed ID: 11916241
DOI: 10.1038/sj.cgt.7700415
|
1432
Morimoto J, Imai S, Haga S, Iwai Y, Iwai M, Hiroishi S, Miyashita N, Moriwaki K, Hosick, H L
New murine mammary tumor cell lines.
In Vitro Cell Dev Biol
1991
27A:349-51
PubMed ID: 2071538
DOI: 10.1007/BF02630952
|
1003
Kiyozuka Y, Asai A, Senzaki H, Uemura Y, Nakashima A, Morimoto J, Matsuzawa A, Tsubura A.
Telomere length, telomerase activity and telomerase RNA expression during mouse mammary tumor progression
Int J Mol Med
1988
2(4):437-44
PubMed ID: 9857231
DOI: 10.3892/ijmm.2.4.437
|
User's Publication |
14659
Okita Y, Kimura M, Xie R, Chen C, Shen LT, Kojima Y, Suzuki H, Muratani M, Saitoh M, Semba K, Heldin CH, Kato M.
The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB
Sci Signal
2017
10(474):eaak9397
PubMed ID: 28400538
DOI: 10.1126/scisignal.aak9397
|
8167
Takekoshi T, Tada Y, Watanabe T, Sugaya M, Hoashi T, Komine M, Kawashima T, Shimizu T, Hau CS, Asahina A, Yokomizo T, Sato S, Tamaki K.
Identification of a novel marker for dendritic cell maturation, mouse transmembrane protein 123.
J. Biol. Chem.
2010
285:31876-84
PubMed ID: 20685650
DOI: 10.1074/jbc.M110.118877
|
6302
Cornils K, Lange C, Schambach A, Brugman MH, Nowak R, Lioznov M, Baum C, Fehse B.
Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance.
Mol Ther
2009
17(1):131-43
PubMed ID: 19002163
DOI: 10.1038/mt.2008.238
|
16430
Montani L, Gerrits B, Gehrig P, Kempf A, Dimou L, Wollscheid B, Schwab ME.
Neuronal Nogo-A modulates growth cone motility via Rho-GTP/LIMK1/cofilin in the unlesioned adult nervous system
J Biol Chem
2009
284(16):10793-807
PubMed ID: 19208621
DOI: 10.1074/jbc.M808297200
|
8849
Beisel KW, Rocha-Sanchez SM, Ziegenbein SJ, Morris KA, Kai C, Kawai J, Carninci P, Hayashizaki Y, Davis RL.
Diversity of Ca2+-activated K+ channel transcripts in inner ear hair cells.
Gene
2007
386:11-23
PubMed ID: 17097837
DOI: 10.1016/j.gene.2006.07.023
|
9058
Galliano MF, Roccasecca RM, Descargues P, Micheloni A, Levy E, Zambruno G, D'Alessio M, Hovnanian A.
Characterization and expression analysis of the Spink5 gene, the mouse ortholog of the defective gene in Netherton syndrome.
Genomics
2005
85:483-92
PubMed ID: 15780751
DOI: 10.1016/j.ygeno.2005.01.001
|